| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 34075 | New Biotechnology | 2009 | 4 Pages |
Abstract
An interview with Alexander von Gabain, CSO of Intercell, one of the leading companies in the area of vaccine development.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Marc Brehme,